Acute Lymphoblastic Leukemia

St. Jude research proves physicians should rely on chemotherapy

Published in Cancer Weekly, July 30th, 2002

Babies treated for acute lymphoblastic leukemia (ALL) whose leukemic cells have a specific chromosomal abnormality do not benefit from bone marrow transplantation, a new study indicates. In fact, these babies have worse outcomes and increased long-term complications from the procedure.

The research indicates that physicians treating these patients should rely on improved chemotherapy.

These results were published in the e journal Lancet by an international team led by Ching-Hon Pui, MD, and William Evans, PharmD, at St. Jude Children's Research Hospital. The study casts new light on treatment for childhood ALL patients with chromosomal 11q23...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-07-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry